What is the 5-year survival rate for patients on dialysis (Dialysis)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

5-Year Survival Rate for Dialysis Patients

The 5-year survival rate for patients on dialysis is approximately 40%, meaning that only 4 out of 10 patients will survive 5 years after initiating dialysis therapy. 1, 2

Survival Data by Time Period

The survival trajectory for dialysis patients shows progressive decline over time:

  • 1-year survival: 84-90% 3, 2
  • 2-year survival: 72-77% 4, 5
  • 3-year survival: 55% 1
  • 5-year survival: 40% 1, 2

This translates to an annual mortality rate exceeding 20% for the dialysis population. 1

Comparison Between Dialysis Modalities

Survival rates are similar between hemodialysis (HD) and peritoneal dialysis (PD), with no significant mortality difference between the two modalities. 2, 6

Specific 5-year survival data by modality:

  • Peritoneal dialysis: 43-56% 5-year survival 4, 5
  • In-center hemodialysis: 35-39% 5-year survival 4, 5
  • Home hemodialysis: 89% 5-year survival (significantly better) 4

Important caveat: PD shows a survival advantage in the first 1.5-2 years of dialysis, but this advantage diminishes over time, with survival rates equalizing or favoring HD after 2 years. 6, 5

Vascular Access Impact on Survival

The type of vascular access dramatically affects survival outcomes in hemodialysis patients:

  • Arteriovenous fistula: 50% 5-year survival 3
  • Prosthetic graft: 41.2% 5-year survival 3
  • Persistent catheter use: 42.9% 5-year survival 3

Patients who temporize with a catheter experience 51% increased mortality compared to those initiating with arteriovenous fistulas. 3

Key Prognostic Factors

Age

Age is the strongest predictor of survival, with nearly a fourfold increase in mortality risk from youngest to oldest age groups. 4

  • Patients under 65 years: >90% 1-year survival 7
  • Patients over 85 years: <15% 5-year survival 7
  • Elderly patients (≥70 years): 20% mortality in first year alone 8

Comorbidities

Several conditions significantly worsen survival:

  • Diabetes mellitus: Associated with worse outcomes compared to polycystic kidney disease or glomerulonephritis 4, 5
  • Cardiovascular disease: Present in 43-58% of dialysis patients and represents the leading cause of death (27% of all deaths) 3, 9, 7
  • Cardiac disease at baseline: 57% increased mortality risk 5

Nutritional Status

Baseline nutritional markers strongly predict survival:

  • Higher serum albumin: 40% reduction in mortality risk per unit increase 5
  • Higher baseline weight: Associated with improved survival 5
  • Higher baseline creatinine: Indicates better muscle mass and nutrition 5

Race

Black patients demonstrate better survival on dialysis compared to white patients (51% increased mortality risk for white patients). 5

Regional Variations

Mortality rates vary by geographic region:

  • China (HD patients): 3.4% annual mortality 3
  • China (PD patients): 2.3% annual mortality 3
  • Zhejiang province (HD): 11.2% annual mortality 3
  • Ningxia province (PD): 8.3% annual mortality 3

These variations likely reflect differences in patient selection, healthcare infrastructure, and comorbidity burden. 3

Common Pitfalls

Do not assume dialysis guarantees long-term survival—the adjusted 5-year survival of only 40% means dialysis extends life but does not normalize life expectancy. 1

Avoid delaying arteriovenous fistula creation—catheter-dependent patients have significantly worse outcomes, with catheter-related bloodstream infections occurring in approximately 50% of patients within 6 months. 3, 2

Do not overlook the importance of timing—there is no mortality benefit to starting dialysis at higher eGFR (10-14 mL/min/1.73 m²) versus lower eGFR (5-7 mL/min/1.73 m²), so avoid premature dialysis initiation. 2

References

Guideline

Prognosis and Management of ESRD Patients Who Refuse Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Patient survival among incident peritoneal dialysis and hemodialysis patients in an urban setting.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000

Research

[Survival and mortality in ESRD patients].

Nephrologie & therapeutique, 2013

Guideline

Mortality in the First Year of Hemodialysis in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Life Expectancy for ESRD Patients Diagnosed in Their 30s

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.